VISN padiopharmaceutical pluvicto drug

Ended Awarded Last action

Contract number
36C24925N0259
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · VISN radiopharmaceutical pluvicto drug DEC MOD -$498,437
Funding Only Action P00002 -$1,462,082
Funding Only Action P00001 · VISN padiopharmaceutical pluvicto drug DEC MOD -$431,979
Original award $2,392,498

About this award

This federal contract award was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency within the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $498,437.10 firm fixed-price contract is for the PLUVICTO drug, a radiopharmaceutical used in cancer treatment and diagnostic imaging. The contract is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a small business set-aside designation. Advanced Accelerator Applications USA Inc. is a subsidiary of Novartis and specializes in developing and producing advanced nuclear medicine solutions, primarily radiopharmaceuticals. This contract supports the VA's provision of critical cancer treatment and diagnostic imaging services to veterans.

Quick answers

Who was awarded contract 36C24925N0259?

36C24925N0259 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on December 20, 2024.

How much is contract 36C24925N0259 worth?

The government has obligated $0 on 36C24925N0259.

Is contract 36C24925N0259 an order under another contract?

Yes. 36C24925N0259 is a BPA call under 36F79719D0169-36C24925A0031, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24925N0259 competed?

The extent of competition for 36C24925N0259 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award